Incomplete Protection against Dengue Virus Type 2 Re-infection in Peru

BACKGROUND: Nearly half of the world’s population is at risk for dengue, yet no licensed vaccine or anti-viral drug is currently available. Dengue is caused by any of four dengue virus serotypes (DENV-1 through DENV-4), and infection by a DENV serotype is assumed to provide life-long protection agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Forshey, Brett M., Reiner, Robert C., Olkowski, Sandra, Morrison, Amy C., Espinoza, Angelica, Long, Kanya C., Vilcarromero, Stalin, Casanova, Wilma, Wearing, Helen J., Halsey, Eric S., Kochel, Tadeusz J., Scott, Thomas W., Stoddard, Steven T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746126/
https://www.ncbi.nlm.nih.gov/pubmed/26848841
http://dx.doi.org/10.1371/journal.pntd.0004398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746126/
https://www.ncbi.nlm.nih.gov/pubmed/26848841
http://dx.doi.org/10.1371/journal.pntd.0004398

Ejemplares similares